Skip to content
Disclosery

Vantage Consulting Group Inc

Follow

13F filer, CIK 1843547, VIRGINIA BEACH, VA

Vantage Consulting Group Inc reported $10,492,463 across 5 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001843547-25-000004

Period
2024-12-31
Reported value
$10.5M
Holdings
5
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
POTBELLY CORPnew+164,875$1.55M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001843547-25-000004, largest first. % of portfolio is the value over $10,492,463, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BWBABCOCK & WILCOX ENTERPRISESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,416,200 shares; 2024Q2: 2,416,200 shares; 2024Q3: 2,416,200 shares; 2024Q4: 2,416,200 shares 2,416,200$3.96M37.77%0Timeline
CBUSCIBUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,143,949 shares; 2024Q2: 1,143,949 shares; 2024Q3: 1,143,949 shares; 2024Q4: 1,143,949 shares 1,143,949$3.18M30.31%0Timeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 850,737 shares; 2024Q2: 850,737 shares; 2024Q3: 850,737 shares; 2024Q4: 850,737 shares 850,737$1.69M16.14%0Timeline
POTBELLY CORPPOTBELLY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: 164,875 shares 164,875$1.55M14.8%new
FIBROGEN INCFIBROGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 195,707 shares; 2024Q2: 195,707 shares; 2024Q3: 195,707 shares; 2024Q4: 195,707 shares 195,707$104K0.99%0

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001843547-25-000004 base2025-02-12acceptance time not in the bulk data set